Publikation: Synthesis and X-ray structure analysis of cytotoxic heptacoordinate sulfonamide salan titanium(IV)-bis-chelates
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
A series of novel sulfonamide substituted heteroleptic salan titanium(iv)-bis-chelates complexed to 2,6-pyridinedicarboxylic acid were synthesized, structurally characterized and evaluated for their anticancer activity against two human carcinoma cell lines. All cytotoxic complexes showed complete inhibition of cell growth at active concentration, two complexes based on pyrrolidine and azepane substituted sulfonamides displayed IC50 values below 1.7 μM and are more cytotoxic than cisplatin in both tested cell lines. The azepane substituted complex exhibited excellent activity with an IC50 value of 0.5 ± 0.1 μM in Hela S3 and 1.0 ± 0.1 μM in Hep G2.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
ZHAO, Tiankun, Martin GRÜTZKE, Kathrin H. GÖTZ, Tetiana DRUZHENKO, Thomas HUHN, 2015. Synthesis and X-ray structure analysis of cytotoxic heptacoordinate sulfonamide salan titanium(IV)-bis-chelates. In: Dalton Transactions. 2015, 44(37), pp. 16475-16485. ISSN 1477-9226. eISSN 1477-9234. Available under: doi: 10.1039/c5dt01618eBibTex
@article{Zhao2015-09-15Synth-32224, year={2015}, doi={10.1039/c5dt01618e}, title={Synthesis and X-ray structure analysis of cytotoxic heptacoordinate sulfonamide salan titanium(IV)-bis-chelates}, number={37}, volume={44}, issn={1477-9226}, journal={Dalton Transactions}, pages={16475--16485}, author={Zhao, Tiankun and Grützke, Martin and Götz, Kathrin H. and Druzhenko, Tetiana and Huhn, Thomas} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/32224"> <dc:creator>Huhn, Thomas</dc:creator> <dc:creator>Grützke, Martin</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2015-11-23T14:49:04Z</dcterms:available> <dc:contributor>Götz, Kathrin H.</dc:contributor> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/32224/1/Zhao_0-308422.pdf"/> <dc:contributor>Zhao, Tiankun</dc:contributor> <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/3.0/"/> <dcterms:issued>2015-09-15</dcterms:issued> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/32224"/> <dc:contributor>Huhn, Thomas</dc:contributor> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dc:language>eng</dc:language> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/> <dc:contributor>Grützke, Martin</dc:contributor> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/32224/1/Zhao_0-308422.pdf"/> <dcterms:abstract xml:lang="eng">A series of novel sulfonamide substituted heteroleptic salan titanium(iv)-bis-chelates complexed to 2,6-pyridinedicarboxylic acid were synthesized, structurally characterized and evaluated for their anticancer activity against two human carcinoma cell lines. All cytotoxic complexes showed complete inhibition of cell growth at active concentration, two complexes based on pyrrolidine and azepane substituted sulfonamides displayed IC50 values below 1.7 μM and are more cytotoxic than cisplatin in both tested cell lines. The azepane substituted complex exhibited excellent activity with an IC50 value of 0.5 ± 0.1 μM in Hela S3 and 1.0 ± 0.1 μM in Hep G2.</dcterms:abstract> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2015-11-23T14:49:04Z</dc:date> <dc:rights>Attribution 3.0 Unported</dc:rights> <dcterms:title>Synthesis and X-ray structure analysis of cytotoxic heptacoordinate sulfonamide salan titanium(IV)-bis-chelates</dcterms:title> <dc:contributor>Druzhenko, Tetiana</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:creator>Druzhenko, Tetiana</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/> <dc:creator>Götz, Kathrin H.</dc:creator> <dc:creator>Zhao, Tiankun</dc:creator> </rdf:Description> </rdf:RDF>